Michael Maher to join LMS board of directors
October 02 2006 - 8:30AM
PR Newswire (US)
MONTREAL, Oct. 2 /PRNewswire-FirstCall/ -- LMS Medical Systems
(AMEX:LMZ; TSX:LMZ), a healthcare technology company and developer
of the CALM(TM) clinical information system and risk management
software tools for obstetrics announced today that Mr. Michael
Maher has agreed to join its board of directors. The appointment is
subject to the approval of the Toronto Stock Exchange. Based in New
York, Mr. Maher holds forty years of Wall Street investment
business experience having most recently served as a Managing
Director of Merrill Lynch guiding a move to closer integration of
the asset base of individual clients with the needs of large
institutional investors. Prior thereto, Mr. Maher served as a
senior Vice-President of Lehman Bros. and as Managing Director and
a member of the Board of Directors of Morgan Grenfeld, C. J.
Lawrence. His two decades at Morgan Grenfeld, C. J. Lawrence
culminated in assisting in its merger and integration into Deutsche
Bank. Mr. Maher serves on the board of The Gregorian University
Foundation, the largest University in Rome. Being an avid pianist,
he also serves as Vice Chairman of a New Jersey based symphony.
"Having Michael Maher agree to serve in a stewardship role is a
valuable addition for the Company", said Benoit LaSalle, Chairman
of the Board "His experience, public market acumen and networking
capabilities are well known and highly respected." About LMS: LMS
is a leader in the application of advanced mathematical modeling
and neural networks for medical use. The LMS CALM(TM) Suite
provides physicians, nursing staff, risk managers and hospital
administrators with clinical information systems and risk
management tools designed to improve outcomes and patient care for
mothers and their infants during childbirth. Except for historical
information contained herein, the matters discussed in this news
release are forward-looking statements. Because these
forward-looking statements involve risks and uncertainties, there
are important factors that could cause actual results to differ
materially from those expressed implied by the forward-looking
statements including, but without limitation, economic conditions
in general and in the healthcare market, the demand for and market
for our products in domestic and international markets, our current
dependence on the CALM product suite, the challenges associated
with developing new products and obtaining regulatory approvals if
necessary, research and development activities, the uncertainty of
acceptance of our products by the medical community, the lengthy
sales cycle for our products, third party reimbursement,
competition in our markets, including the potential introduction of
competitive products by others, our dependence on our distributors,
physician training, enforceability and the costs of enforcement of
our patents, potential infringements of our patents and the other
factors set forth from time to time in the Company's filings with
the United States Securities and Exchange Commission and with the
Canadian Securities Commissions. The Company has no intention of or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.
DATASOURCE: LMS MEDICAL SYSTEMS INC. CONTACT: Andrea Miller,
Communications, LMS Medical Systems Inc., (514) 488-3461 Ext. 222,
Fax: (514) 488-1880, , http://www.lmsmedical.com/; David
Gordon/Grant Howard, The Howard Group Inc., 1-888-221-0915, ,
http://www.howardgroupinc.com/
Copyright